Literature DB >> 1603724

Neuropsychological assessment.

D Tranel1.   

Abstract

The aging population of the United States and many other countries guarantees that disorders common in elderly persons will continue to become more prevalent. In the past decade or so, we already have witnessed the beginning of this trend, with the rapid rise in the number of patients with degenerative dementia, especially Alzheimer's disease. On another track, sophisticated and timely medical and surgical interventions have produced a growing number of patients who survive serious head injury. These patients are typically young, and may live for many decades after their brain injury. In both examples, a core feature of the condition is impaired cognition and behavior; that is, defects in higher-level capacities such as memory, intellectual function, language, and decision-making. Neuropsychological assessment cannot be viewed as a luxury in cases such as these but rather, as a vital component of the neurodiagnostic evaluation. The neuropsychologist uses a set of standardized instruments to measure cognition and behavior in a comprehensive and precise manner, yielding rich information that may assist in accurate diagnosis, prudent management, and optimal rehabilitation. The neuropsychological examination may provide the only means with which to detect alterations in brain function, as in cases of mild head injury or low-level toxic exposure, which may not be revealed through other procedures. Finally, neuropsychological assessment will continue to play a key role in the scientific programs that are dedicated to advancing our understanding of the neural substrates of complex behavior.

Entities:  

Mesh:

Year:  1992        PMID: 1603724

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  5 in total

1.  Association between birthweight and cognitive function in middle age: the atherosclerosis risk in communities study.

Authors:  Antonio José Leal Costa; Pauline Lorena Kale; Ronir Raggio Luiz; Suzana Alves De Moraes; Thomas H Mosley; Moyses Szklo
Journal:  Ann Epidemiol       Date:  2011-07-23       Impact factor: 3.797

2.  Orthostatic hypotension and cognitive function: the Atherosclerosis Risk in Communities Study.

Authors:  Kathryn M Rose; David Couper; Marsha L Eigenbrodt; Thomas H Mosley; A Richey Sharrett; Rebecca F Gottesman
Journal:  Neuroepidemiology       Date:  2009-11-05       Impact factor: 3.282

3.  Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension.

Authors:  Roberto Fogari; Amedeo Mugellini; Annalisa Zoppi; Gianluigi Marasi; Carlo Pasotti; Luigi Poletti; Andrea Rinaldi; Paola Preti
Journal:  Eur J Clin Pharmacol       Date:  2004-01-28       Impact factor: 2.953

4.  n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  May A Beydoun; Jay S Kaufman; Philip D Sloane; Gerardo Heiss; Joseph Ibrahim
Journal:  Public Health Nutr       Date:  2007-07-12       Impact factor: 4.022

5.  Measurement error adjustment in essential fatty acid intake from a food frequency questionnaire: alternative approaches and methods.

Authors:  May A Beydoun; Jay S Kaufman; Joseph Ibrahim; Jessie A Satia; Gerardo Heiss
Journal:  BMC Med Res Methodol       Date:  2007-09-14       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.